Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
DiaMedica Therapeutics Inc. market cap for the quarter ending 2026-08-03 was $350.52M, a 44.90% increase year-over-year.
DiaMedica Therapeutics Inc. market cap for the quarter ending 2026-06-30 was $379.37M, a 126.71% increase year-over-year.
DiaMedica Therapeutics Inc. market cap for the quarter ending 2026-05-04 was $325.72M, a 107.53% increase year-over-year.
DiaMedica Therapeutics Inc. market cap for the quarter ending 2026-03-31 was $364.79M, a 124.57% increase year-over-year.
DiaMedica Therapeutics Inc. market cap for fiscal 2026 was $350.52M.
DiaMedica Therapeutics Inc. market cap for fiscal 2025 was $427.25M, a 83.76% increase from fiscal 2024.
DiaMedica Therapeutics Inc. market cap for fiscal 2024 was $232.51M, a 115.68% increase from fiscal 2023.
DiaMedica Therapeutics Inc. market cap for fiscal 2023 was $107.8M, a 158.00% increase from fiscal 2022.